Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481702
Status:
COMPLETED
Last Update Posted:
2017-02-20
First Post:
2007-06-01
Brief Title:
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus CeftriaxoneMetronidazole in the Treatment of Intra-abdominal Infections in Adults 0826-802
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Prospective Multicenter Open-Label Randomized Comparative Study to Evaluate the Efficacy Safety and Tolerability of Ertapenem Versus CeftriaxoneMetronidazole in the Treatment of Intra-Abdominal Infections in Adults
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multicenter study to evaluate the effectiveness of ertapenem compared to ceftriaxonemetronidazole in treating certain abdominal infections that require surgery in adult patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_558 | None | None | None |